Condition: Carcinoma, Adenoid Cystic · Head and Neck Cancer · Sponsor: CNAO National Center of Oncological Hadrontherapy
The investigators aim at investigating in a prospective clinical trial whether using a Simoultaneous Integrated Boost of carbon ions treatment planning approach, improving the tumor dose conformation while lowering the unintended dose to the low-risk volume, can significantly reduce the probability of toxicity without affecting Local Control.
This description comes directly from the study's public registry record.
Sara Ronchi, MD · +390382078501 · sara.ronchi@cnao.it
Cristina Bono, MSc · 0382078613 · cristina.bono@cnao.it
Always discuss trial participation with your own doctor first.
| CNAO | Pavia, Pavia, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05733910